The global Veterinary Vaccines Market size was estimated at USD 8,930 million in 2024 and is projected to reach USD 12,733.9 million in 2031 at a CAGR of 5.20 % during the forecast period 2025-2031.
The global veterinary vaccines market refers to the segment of the healthcare industry focused on the development, production, and distribution of vaccines designed to prevent infectious diseases in animals. These vaccines are critical in protecting livestock, pets, and wildlife from a wide array of diseases that could otherwise have significant economic, environmental, and public health consequences. The market encompasses both companion animal vaccines, which protect pets like dogs and cats, and livestock vaccines aimed at cattle, poultry, swine, and other farm animals. Veterinary vaccines play a pivotal role in disease prevention, promoting animal health, and ensuring food security.
Get Free Sample Report: https://www.delvens.com/get-free-sample/veterinary-vaccines-market
The scope of the global veterinary vaccines market is expanding due to several factors. Increased awareness of animal health, growing concerns about zoonotic diseases, and rising pet ownership have spurred demand for vaccines across various regions. Technological advancements in vaccine development, such as recombinant DNA technology, mRNA vaccines, and improved delivery systems, have enhanced the effectiveness and safety of vaccines.
Key Findings:
The livestock vaccines segment is projected to remain the largest in the global veterinary vaccines market, driven by the increasing demand for animal-derived food products and the growth of livestock farming.
The companion animal vaccines segment is also expected to witness significant growth, fueled by the increasing pet population and the rising awareness of pet healthcare. Pet owners are becoming more proactive in ensuring the well-being of their animals, leading to higher vaccination rates.
The veterinary hospitals segment, as the primary end user of veterinary vaccines, is expected to hold the largest share of the market. This is due to the rising ownership of companion animals, the increasing population of livestock, and the growing demand for animal-derived food in emerging economies, all of which drive the need for veterinary care.
Recent Developments
In November 2024, Ceva (France) announced the construction of a new vaccine manufacturing facility in Monor, Hungary. The 7,000 m² plant will feature state-of-the-art technologies and focus on producing fermentation-based multicomponent inactivated vaccines for animals, enhancing Ceva's global production capacity.
In September 2024, Merck & Co., Inc. (US) revealed the expansion of its NOBIVAC NXT platform with the introduction of a pioneering new vaccine for Feline Leukemia Virus (FeLV). This vaccine is the first to utilize RNA-Particle Technology, providing a novel solution for preventing FeLV in cats.
In November 2024, Boehringer Ingelheim International GmbH (Germany) launched the EURICAN L4 vaccine, aimed at protecting dogs from leptospirosis, a reemerging and severe infectious disease that poses a growing threat to canine health.
Competitive Landscape
- Zoetis
- Merck & Co., Inc.
- Boehringer Ingelheim
- Elanco
- Virbac
- Ceva
- Phibro Animal Health
- Hester Biosciences
- Neogen and
For More Inquiry@: https://www.delvens.com/Inquire-before-buying/veterinary-vaccines-market
Regional Analysis:
North America to Dominate the Market
- North America is expected to maintain a leading position in the global animal vaccines market, driven by the high prevalence of livestock and zoonotic diseases that result in significant animal losses.
- In Europe, the animal vaccines market is set to grow steadily, supported by the large populations of both production and companion animals. The region boasts significant pet ownership, with millions of households owning pets, which drives demand for vaccines.
The Global Veterinary Vaccines Market is segmented into various segments such as Type, Technology, Route of Administration, End-User and Region.
Based on Type
- Porcine
- Poultry
- Livestock
- Companion Animals
Based on Technology
- Live Attenuated
- Inactivated
- Toxoid
Based on Route of Administration
- Intramuscular
- Subcutaneous
- Oral
Based on End-User
- Hospitals
- Clinics
Based on region:
- Asia Pacific
- North America
- Europe
- South America
- Middle East & Africa
Get Complete Info@: https://www.delvens.com/report/veterinary-vaccines-market
Frequently Asked Questions
- What are the years considered to study Veterinary Vaccines Market intelligence report?
- What is the compound annual growth rate (CAGR) of the Veterinary Vaccines Market?
- Which region holds the largest market share in Veterinary Vaccines Market?
- Which region is the fastest growing in Veterinary Vaccines Market?
- Who are the major players in Veterinary Vaccines Market?
In addition to the market data for the Global Veterinary Vaccines Market, Delvens offers client-centric reports customized according to the company’s specific demand and requirements. More Related Reports:
Biosimilars Market
Human Organoids Market
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact us:
Unit No. 01, 3rd Floor, Plot No. 56, Block B
Sector 2 Noida, Near Noida Sector 15 Metro Station 201301, IN
+44 20 3290 6466
+0120- 4903958
[email protected]